Hiroki Tojima

10PUBLICATIONS
48CO-AUTHORS
Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Radiation therapySocial program evaluationEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 16, 2026
Trends in the Proportion of Hepatitis C Virus Antibody-Positive Patients Who Could be Considered for Direct-Acting Antiviral Therapy Identified Through Preoperative Testing for Ophthalmic Surgery: A Nationwide Multicenter Real-World Cohort Study in Japan.

|Sep 15, 2026
Prognostic Value of the FIB-3 Index in Patients With Hepatic Encephalopathy Receiving Rifaximin: A Multicenter Retrospective Analysis.

|Apr 29, 2026
Efficacy and Safety of Stereotactic Body Radiation Therapy in Patients With Hepatocellular Carcinoma in the Caudate Lobe: A Comparative Study With Radiofrequency Ablation.

|Apr 01, 2026
Long-Term Outcomes of Sofosbuvir/Velpatasvir Treatment for Hepatitis C Virus-Related Decompensated Cirrhosis: A Retrospective Multicenter Cohort Study.

Satoru Kakizaki, Tadashi Ikegami, Takeshi Hatanaka

|Jan 08, 2026
Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study.

Satoshi Takakusagi, Satoru Kakizaki, Yozo Yokoyama

|Apr 13, 2022
Adolescents with chronic hepatitis C might be good candidates for direct-acting antiviral therapy.

Ken Sato, Yuichi Yamazaki, Yuki Kanayama

Pageof 2

Frequent Collaborators

8 joint publications

Takeshi Hatanaka

6 joint publications

Atsushi Naganuma

6 joint publications

Satoru Kakizaki

5 joint publications

Toshio Uraoka